Trial
NCT05650567
Study of M5049 in DM and PM Participants (NEPTUNIA)
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
EMD Serono Research & Development Institute, Inc.
Collaborators
Merck KGaA, Darmstadt, Germany
Condition
Dermatomyositis
Intervention
M5049 high dose
Why stopped
Based on interim analyses for futility
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-17